[18F]FDG Dual

Commercially available: ready to use consumables and optimized method

Application

[18F]FDG is used in PET for diagnosing, staging and monitoring treatment of cancers, particularly in Hodgkin's disease, non-Hodgkin's lymphoma, colorectal cancer, breast cancer, melanoma and lung cancer.

Configuration

This process can operate on any AllinOne model. The FDG Dual process allows the preparation of two consecutive productions of FDG on the AllinOne automated synthesizer using only one cassette and one reagent kit.

It is not available for commercial use until 05/2017 in the USA.

Advantages

  • Cost effective: load once, run twice
  • Two back to back runs in one single hot cell
  • Reduces user’s radiation exposure
  • State-of-the-art yields at both runs
  • Plug and play GMP consumables; all accessories included; no laboratory bench preparation

Performances

Cassette and reagents set up time < 1 min
Synthesis time 26 min
Typical production yield 70 ± 4% decay un-corrected
Radiochemical purity ≥ 98%

Denominations

Fludeoxyglucose (18F) or fludeoxyglucose F 18 (USAN and USP), also commonly called fluorodeoxyglucose and abbreviated [18F]FDG, 18F-FDG or FDG